Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients.
Chun-Rong Ju, Qiao-Yan Lian, Jian-Heng Zhang, Tao Qiu, Zhi-Tao Cai, Wen-Yang Jiang, Jing Zhang, Qin Cheng, Gang Chen, Ning Li, Chun-Yan Wang, Jian-Xing He
Author Information
Chun-Rong Ju: State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
Qiao-Yan Lian: State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
Jian-Heng Zhang: State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
Tao Qiu: Department of Kidney Transplantation, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Zhi-Tao Cai: Department of Kidney Transplantation, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Wen-Yang Jiang: Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Jing Zhang: Department of Cardiovascular Surgery, Affiliated Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.
Qin Cheng: Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing 100083, China.
Gang Chen: Department of Kidney Transplantation, Affiliated Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430071, China.
Ning Li: Department of Kidney Transplantation, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Chun-Yan Wang: Department of Hematology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
Jian-Xing He: State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
Since December 2019, increasing attention has been paid to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in Wuhan, China. SARS-CoV-2 primarily invades the respiratory tract and lungs, leading to pneumonia and other systemic disorders. The effect of SARS-CoV-2 in transplant recipients has raised significant concerns, especially because there is a large population of transplant recipients in China. Based on the current epidemic situation, this study reviewed publications on this virus and coronavirus disease 2019 (COVID-19), analyzed common features of respiratory viral pneumonias, and presented the currently reported clinical characteristics of COVID-19 in transplant recipients to improve strategies regarding the diagnosis and treatment of COVID-19 in this special population.
